Data / Form D filings / AMARIN CORP PLC\UK
AMARIN CORP PLC\UK: Form D filing
AMARIN CORP PLC\UK, a pharmaceuticals company in Dublin, filed a Form D with the SEC in 2009. The latest, on October 30, 2009, reports $70 million sold of a $70 million offering to 36 investors.
Find out what AMARIN CORP PLC\UK does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- FIRST FLOOR, BLOCK 3, THE OVAL,, SHELBOURNE ROAD, BALLSBRIDGE, Dublin, Dubli
- Phone
- 353 1 6699 020
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- United Kingdom
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 897448
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 30, 2009 | New notice | $70,000,000 | $70,000,000 | $0 | 36 | Oct 16, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alan L. Cooke | Executive Officer | |
| Carl L. Gordon | Director | |
| Joseph L. Anderson | Director | |
| Lars L. Ekman | Director | |
| Thomas G. Lynch | Executive Officer, Director | |
| Manus L. Rogan | Director | |
| James I. Healy | Director |
Every Form D from the week of Oct 26, 2009 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what AMARIN CORP PLC\UK reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.